TUBA4A

Chr 2ADAR

tubulin alpha 4a

Also known as: ALS22, CMYO26, FTDALS9, H2-ALPHA, OZEMA23, SPAX11, TUBA1

Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulin. The genes encoding these microtubule constituents are part of the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes and they are highly conserved among and between species. This gene encodes an alpha tubulin that is a highly conserved homolog of a rat testis-specific alpha tubulin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2013]

OMIMResearchGenerating clinical summary…
DNmechanismAD/ARLOEUF 0.624 OMIM phenotypes
Clinical SummaryTUBA4A
🧬
Gene-Disease Validity (ClinGen)
amyotrophic lateral sclerosis type 22 · ADModerate

Moderate evidence — consider for supplementary testing

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.27) despite low pLI — interpret in context.
📋
ClinVar Variants
24 unique Pathogenic / Likely Pathogenic· 34 VUS of 123 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.62LOEUF
pLI 0.160
Z-score 2.60
OE 0.27 (0.130.62)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
3.30Z-score
OE missense 0.44 (0.380.51)
120 obs / 273.8 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.27 (0.130.62)
00.351.4
Missense OE?0.44 (0.380.51)
00.61.4
Synonymous OE?0.99
01.21.6
LoF obs/exp: 4 / 14.8Missense obs/exp: 120 / 273.8Syn Z: 0.07

This gene — mechanism propensity

DN
0.78top 25%
GOF
0.4875th %ile
LOF
0.3746th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNTUBA4A mutants act as dominant negatives to alter microtubule dynamics and stability1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 25374358

ClinVar Variant Classifications

123 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic7
VUS34
Likely Benign45
Benign16
Conflicting1
17
Pathogenic
7
Likely Pathogenic
34
VUS
45
Likely Benign
16
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
10
5
0
17
Likely Pathogenic
4
3
0
0
7
VUS
3
29
1
1
34
Likely Benign
0
1
9
35
45
Benign
0
0
12
4
16
Conflicting
1
Total9432740120

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

30 pathogenic / likely-pathogenic (of 35) ClinVar copy-number / structural variants overlap TUBA4A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TUBA4A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →